Page last updated: 2024-08-23

paclitaxel and Carcinosarcoma

paclitaxel has been researched along with Carcinosarcoma in 56 studies

Research

Studies (56)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.79)	18.2507
2000's	9 (16.07)	29.6817
2010's	35 (62.50)	24.3611
2020's	11 (19.64)	2.80

Authors

Authors	Studies
Bonamino, MH; Chaves, CBP; da Silva, JL; de Albuquerque, LZ; de Melo, AC; de Mesquita, GG; Rodrigues, FR	1
Clarke, A; Day, E; de la Rosa, CN; Fiorentino, F; Krell, J; Reddi, M; Webber, L	1
Copeland, LJ; DiSilvestro, PA; Filiaci, VL; Hensley, ML; Huang, HQ; Ioffe, OB; Miller, DS; Moore, KN; Mutch, DG; Powell, MA; Santin, A; Secord, AA; Spirtos, NM; Tewari, KS; Warshal, DP	1
Matei, D; Roque, DR	1
Wang, PH; Yang, ST	1
Crane, E	1
Bijlsma, RM; Franken, MD; Röckmann-Helmbach, H	1
Mandilaras, V; Park, CL; Rajadurai, CV; Ton Nu, TN	1
Fujiwara, Y; Ishikawa, M; Kato, T; Kojima, Y; Nishikawa, T; Noguchi, E; Ohtake, Y; Okuma, H; Seo, T; Shimomura, A; Sudo, K; Tamura, K; Tanioka, M; Uehara, T; Uno, M; Yonemori, K	1
Economos, K; Friedman, M; Gorelick, C; Heyman, T; Kanis, MJ; Lee, YC; McEachron, J; Shanahan, L; Singhal, PK; Tran, V	1
Ebata, T; Fujiwara, K; Fujiwara, Y; Hasegawa, K; Kato, T; Nishikawa, T; Noguchi, E; Shimomura, A; Sudo, K; Tamura, K; Yonemori, K	1
Aoyama, Y; Harada, H; Hoshino, K; Kagami, S; Kinjo, Y; Kuradome, Y; Murakami, M; Ueda, T; Yoshino, K	1
Adachi, S; Baba, T; Blake, EA; Bush, SH; Hasegawa, K; Ikeda, Y; Im, DD; Iwasaki, K; Johnson, MS; Kelley, JL; Klobocista, MM; Machida, H; Matsuo, K; Miyake, TM; Nagano, T; Nishimura, M; Omatsu, K; Pejovic, T; Roman, LD; Ross, MS; Satoh, S; Shahzad, MMK; Shida, M; Takano, T; Takekuma, M; Takeuchi, S; Ueda, Y; Ueland, FR; Yanai, S; Yokoyama, T; Yunokawa, M	1
Brackmann, M; Erba, J; McLean, K; Reynolds, RK; Stasenko, M; Uppal, S	1
Chang, CW; Chen, CH; Cheng, CJ; Chiu, YH; Fu, HS; Liu, WM; Wang, ID; Wu, YC	1
Bryant, A; Das, N; Galaal, K; Godfrey, K; Kucukmetin, A; Lopes, AD; Naik, R; van der Heijden, E	1
Altundağ, Ö; Ayhan, A; Dizdar, O; Dursun, P; Kucukoztas, N; Ozen, O; Rahatli, S; Reyhan, NH; Tarhan, C; Yalcin, S; Yildiz, F	1
Baba, T; Konishi, I; Mandai, M; Matsumura, N; Mikami, Y; Takamatsu, S	1
Izuta, C; Kaseki, H; Matsuura, T; Otsuka, I; Sato, M; Suzuki, Y; Takagi, K; Takaya, H; Tanaka, A	1
Antoine, M; Bonnette, P; Cadranel, J; Cazes, A; Duruisseaux, M; Girard, N; Mazieres, J; Monnet, I; Ung, M; Vieira, T; Wislez, M	1
Fujimoto, T; Ito, K; Kagabu, M; Kigawa, J; Kurachi, H; Matsumoto, T; Mizunuma, H; Nagase, S; Nakahara, K; Niikura, H; Nishiyama, H; Otsuki, T; Sato, N; Sato, S; Shimada, M; Shoji, T; Soeda, S; Sugiyama, T; Takano, T; Tase, T; Terada, Y; Tokunaga, H; Toyoshima, M; Utsunomiya, H; Yaegashi, N; Yamada, H; Yokoyama, Y	1
Borger, D; Bradford, LS; Clark, RM; Foster, R; Groeneweg, JW; Growdon, WB; Rauh-Hain, A; Rueda, BR; Zhang, L; Zukerberg, LR	1
Ditto, A; Lorusso, D; Mancini, M; Martinelli, F; Raspagliesi, F; Sarno, I	1
Bertrand, M; Colombo, PE; Fabbro, M; Gutowski, M; Labaki, M; Mollevi, C; Mourregot, A; Quenet, F; Rouanet, P; Saint-Aubert, B	1
Arakawa, A; Futagami, M; Kamoi, S; Katabuchi, H; Katsuta, T; Kotera, K; Kudaka, W; Nishiyama, H; Nomura, H; Otsuki, A; Sato, N; Shibata, K; Shimada, M; Watanabe, Y; Yaegashi, N; Yokoyama, Y	1
Becker, MA; Enderica-Gonzalez, S; Glaser, G; Haluska, P; Harrington, SC; Hou, X; Weroha, SJ	1
Chu, C; Lin, LL; Rubin, S; Xu, MJ	1
Dickson, EL; Dottino, J; Fader, AN; Gehrig, PA; Geller, MA; Havrilesky, L; Pierce, S; Ricci, S; Secord, AA; Vogel, RI	1
Fujiwara, K; Hanaoka, T; Hasegawa, K; Iwasa, N; Kurosaki, A; Nagao, S; Nishikawa, T	1
Hazan, E; Sahu, J; Santa, E	2
Economopoulos, T; Panayiotides, J; Papachristodoulou, A; Papaxoinis, G; Pectasides, D; Pectasides, E; Sykiotis, C; Tountas, N; Xiros, N	1
Abu-Rustum, NR; Aghajanian, CA; Alektiar, KM; Hensley, ML; Iasonos, A; Makker, V; Zhou, Q	1
A'Hern, R; Ang, JE; Blake, P; Coombes, I; Everard, M; Gabra, H; Gore, ME; Hall, G; Jenkins, A; Jones, RL; Kaye, SB; Keyzor, C; Shah, RN; Thomas, K	1
Bond, VK; Im, DD; Matsuo, K; Rosenshein, NB	1
Degeest, K; Filiaci, VL; Hanjani, P; Mannel, RS; Miller, BE; Powell, MA; Rose, PG; Susumu, N; Ueland, FR	1
Fujiwara, K; Kamiura, S; Masuhara, K; Miyoshi, A; Ohta, Y; Okazawa, M; Tomita, Y; Yoshino, K	1
Atkinson, EN; Brown, J; Burke, TW; Coleman, RL; Euscher, E; Gano, JB; Lacour, RA; Ramirez, PT; Ramondetta, LM; Sun, CC	1
Kagami, S; Mori, M; Namba, Y; Sugano, T; Uenami, T; Yokota, S	1
Balakrishnan, K; Natarajaseenivasan, K; SenthilKumar, G; Shanmughapriya, S; Vasanthi, N; Vinodhini, K	1
Camporeale, A; Cormio, G; De Mitri, P; Falagario, M; Loizzi, V; Putignano, G; Scardigno, D; Selvaggi, LE	1
Choijamts, B; Emoto, M; Iwasaki, H; Jimi, S; Kondo, T; Kuroki, M; Matsumoto, T; Naganuma, Y	1
Chun, KC; Kim, DY; Kim, JH; Kim, JJ; Kim, YM; Kim, YT; Nam, JH	1
Bellone, S; Carrara, L; Emiliano, C; Guzzo, F; Pecorelli, S; Roque, DM; Rutherford, TJ; Santin, AD; Sartori, E; Schwartz, PE	1
Chang, CC; Wu, CC	1
Amant, F; Neven, P; Vandenput, I; Vergote, I	1
Aynaoglu, G; Kahraman, K; Kankaya, D; Ortac, F	1
Aghajanian, C; Powell, MA; Secord, AA; Sill, MW; Steinhoff, M	1
Kang, S; Lim, MC; Lim, S; Park, JY; Park, SY; Seo, SS; Yoo, HJ	1
Akahira, J; Ito, K; Matsunaga, G; Niikura, H; Tase, T; Toyoshima, M; Yaegashi, N	1
Gold, MA; Huh, WK; Johnson, GA; Lewin, SN; Mannel, RS; McMeekin, DS; Mutch, DG; Powell, MA; Rutledge, TL; Walker, JL	1
Bitterman, P; Eaton, L; Filiaci, V; Homesley, HD; Kilgore, LC; Markman, M; Monk, BJ; Ueland, FR	1
Berchuck, A; Carney, ME; Clarke-Pearson, DL; Havrilesky, LJ; Rodriguez, GC; Secord, AA; Soper, JT	1
Aydin, Y; Cicin, I; Eralp, Y; Ozluk, Y; Saip, P; Selam, M; Topuz, E; Topuz, S	1
Carriero, C; Cormio, G; Di Vagno, G; Fontana, A; Greco, P; Loverro, G; Melilli, GA; Selvaggi, L	1
Blessing, JA; Curtin, JP; DeGeest, K; Soper, JT	1

Reviews

7 review(s) available for paclitaxel and Carcinosarcoma

Article	Year
Beyond Serous: Treatment Options for Rare Endometrial Cancers. Current treatment options in oncology, 2022, Volume: 23, Issue:11 Topics: Carboplatin; Carcinosarcoma; Endometrial Neoplasms; Female; Humans; Lymph Node Excision; Paclitaxel	2022
An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of Literature. Current oncology (Toronto, Ont.), 2023, 05-10, Volume: 30, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Colorectal Neoplasms; Female; Humans; Paclitaxel	2023
Hypersensitivity Reaction to Carboplatin in Gynecologic Cancer: A Case Report and a Review of the Literature. Journal of UOEH, 2021, Volume: 43, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Drug Hypersensitivity; Drug Substitution; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Treatment Outcome; Uterine Neoplasms	2021
Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. The Cochrane database of systematic reviews, 2013, Feb-28, Issue:2 Topics: Antineoplastic Agents, Alkylating; Carcinosarcoma; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Paclitaxel; Radiotherapy; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Uterine Neoplasms	2013
[Carcinosarcoma of the ovary treated with paclitaxel and carboplatin chemotherapy - a report of 4 cases]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Combined Modality Therapy; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel	2013
Carcinosarcoma of the ovary: analysis of 13 cases and review of the literature. Oncology, 2011, Volume: 80, Issue:1-2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; CA-19-9 Antigen; Carboplatin; Carcinosarcoma; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Humans; Ifosfamide; Middle Aged; Mucin-1; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Survival Rate; Treatment Outcome	2011
[Chemotherapy in the treatment of ovarian carcinosarcoma]. Minerva ginecologica, 1999, Volume: 51, Issue:11 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Retrospective Studies	1999

Trials

12 trial(s) available for paclitaxel and Carcinosarcoma

Article	Year
Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE). Trials, 2022, Jan-05, Volume: 23, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Fallopian Tubes; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Quality of Life	2022
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 03-20, Volume: 40, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease-Free Survival; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Uterine Neoplasms	2022
Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study. International journal of clinical oncology, 2014, Volume: 19, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease-Free Survival; Female; Humans; Japan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Uterine Neoplasms; Uterus	2014
Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Combined Modality Therapy; Feasibility Studies; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Survival Rate; Uterine Neoplasms	2015
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Endometrial Neoplasms; Feasibility Studies; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel	2009
Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jun-01, Volume: 28, Issue:16 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinosarcoma; Confidence Intervals; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Kaplan-Meier Estimate; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Probability; Prognosis; Program Evaluation; Risk Assessment; Survival Analysis; Treatment Outcome; Uterine Neoplasms	2010
A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Survival Rate; Treatment Outcome; Uterine Neoplasms	2011
Weekly paclitaxel-carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies	2012
Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study. Gynecologic oncology, 2012, Volume: 126, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carboplatin; Carcinosarcoma; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Uterine Neoplasms	2012
Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma. Archives of gynecology and obstetrics, 2012, Volume: 286, Issue:6 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease-Free Survival; Female; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Sarcoma, Endometrial Stromal; Uterine Neoplasms	2012
Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Feb-10, Volume: 25, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Prospective Studies; Treatment Outcome; United States; Uterine Neoplasms	2007
Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecologic oncology, 2001, Volume: 83, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinosarcoma; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Uterine Neoplasms	2001

Other Studies

37 other study(ies) available for paclitaxel and Carcinosarcoma

Article	Year
The prevalence and prognostic impact of tumor-infiltrating lymphocytes in uterine carcinosarcoma. BMC cancer, 2021, Dec-07, Volume: 21, Issue:1 Topics: Aged; Antineoplastic Agents; B7-H1 Antigen; Biomarkers, Tumor; Carboplatin; Carcinosarcoma; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphocytes, Tumor-Infiltrating; Middle Aged; Paclitaxel; Prevalence; Prognosis; Programmed Cell Death 1 Receptor; Signal Transduction; Tumor Microenvironment; Uterine Neoplasms	2021
Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to Inclusion. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 03-20, Volume: 40, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Female; Humans; Paclitaxel; Uterine Neoplasms	2022
Abandon ifosfamide-based regimen and use paclitaxel-carboplatin regimen for the treatment of uterine carcinosarcoma. Journal of the Chinese Medical Association : JCMA, 2022, 05-01, Volume: 85, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Female; Humans; Ifosfamide; Paclitaxel; Uterine Neoplasms	2022
[An exceptional venous pattern in a patient with cancer]. Nederlands tijdschrift voor geneeskunde, 2023, 04-19, Volume: 167 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Endometrial Neoplasms; Female; Humans; Paclitaxel	2023
[Ifosfamide and Paclitaxel for Recurrent or Metastatic Uterine Carcinosarcoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Disease-Free Survival; Female; Humans; Ifosfamide; Paclitaxel; Retrospective Studies	2019
Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020, Volume: 30, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinosarcoma; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Salpingo-oophorectomy; Survival Rate; Uterine Neoplasms	2020
Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma. Oncology, 2020, Volume: 98, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Docetaxel; Doxorubicin; Female; Humans; Ifosfamide; Indazoles; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Progression-Free Survival; Pyrimidines; Retrospective Studies; Sulfonamides; Treatment Outcome; Uterine Neoplasms	2020
Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery. Journal of surgical oncology, 2018, Volume: 117, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Case-Control Studies; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Female; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2018
Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature. BMC cancer, 2018, 02-09, Volume: 18, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease-Free Survival; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Middle Aged; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Treatment Outcome	2018
Primary peritoneal carcinosarcoma: A report of two cases. Taiwanese journal of obstetrics & gynecology, 2019, Volume: 58, Issue:2 Topics: Abdominal Neoplasms; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Fatal Outcome; Female; Humans; Mixed Tumor, Mullerian; Paclitaxel; Peritoneal Neoplasms	2019
Impact of treatment strategies on local control and survival in uterine carcinosarcomas in Turkey. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carboplatin; Carcinosarcoma; Cross-Linking Reagents; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Turkey; Uterine Neoplasms	2013
Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component. The journal of obstetrics and gynaecology research, 2014, Volume: 40, Issue:1 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinosarcoma; Chemotherapy, Adjuvant; Endometrium; Female; Humans; Hypercalcemia; Hysterectomy; Ovariectomy; Paclitaxel; Paraneoplastic Syndromes; Salpingectomy; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms; Uterus	2014
Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Deoxycytidine; Docetaxel; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gemcitabine; Giant Cell Tumors; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Quinazolines; Retrospective Studies; Sarcoma; Survival Rate; Taxoids; Vinblastine; Vinorelbine	2013
Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer. Gynecologic oncology, 2014, Volume: 133, Issue:2 Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Endometrioid; Carcinosarcoma; Class I Phosphatidylinositol 3-Kinases; Endometrial Neoplasms; Female; Humans; Mice; Mice, SCID; Morpholines; Mutation; Paclitaxel; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2014
Carboplatin-Paclitaxel versus Cisplatin-Ifosfamide in the treatment of uterine carcinosarcoma: a retrospective cohort study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Female; Humans; Ifosfamide; Middle Aged; Paclitaxel; Retrospective Studies; Survival Analysis; Uterine Neoplasms	2014
Impact of neoadjuvant chemotherapy cycles prior to interval surgery in patients with advanced epithelial ovarian cancer. Gynecologic oncology, 2014, Volume: 135, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Carcinoma, Ovarian Epithelial; Carcinosarcoma; Cohort Studies; Cystadenocarcinoma, Serous; Cytoreduction Surgical Procedures; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Prognosis; Reoperation; Retrospective Studies; Treatment Outcome; Young Adult	2014
Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft. PloS one, 2015, Volume: 10, Issue:5 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease Models, Animal; Female; Gene Expression Profiling; Humans; Maximum Tolerated Dose; Mice; Molecular Targeted Therapy; Ovarian Neoplasms; Paclitaxel; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays	2015
Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma. American journal of clinical oncology, 2017, Volume: 40, Issue:6 Topics: Abdominal Neoplasms; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Endometrioid; Carcinosarcoma; Chemoradiotherapy; Cohort Studies; Endometrial Neoplasms; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Paclitaxel; Pelvic Neoplasms; Radiotherapy; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Survival Rate; Tumor Burden	2017
A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma. Gynecologic oncology, 2015, Volume: 139, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Disease-Free Survival; Female; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Uterine Neoplasms	2015
The Efficacy of Low-Dose Paclitaxel Added to Combination Chemotherapy of Carboplatin and Gemcitabine or Pegylated Liposomal Doxorubicin. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016, Volume: 26, Issue:3 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cystadenocarcinoma, Serous; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Endometrial Neoplasms; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Pilot Projects; Polyethylene Glycols; Prognosis; Remission Induction; Retrospective Studies; Survival Rate	2016
Diffuse Rash After the Administration of Carboplatin and Paclitaxel. The American Journal of dermatopathology, 2016, Volume: 38, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinosarcoma; Drug Eruptions; Eczema; Exanthema; Female; Humans; Middle Aged; Paclitaxel; Skin; Uterine Neoplasms	2016
Diffuse Rash After the Administration of Carboplatin and Paclitaxel: Answer. The American Journal of dermatopathology, 2016, Volume: 38, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinosarcoma; Drug Eruptions; Eczema; Exanthema; Female; Humans; Middle Aged; Paclitaxel; Skin; Uterine Neoplasms	2016
Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution. Gynecologic oncology, 2008, Volume: 110, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease-Free Survival; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Polyethylene Glycols; Retrospective Studies; Survival Rate; Uterine Neoplasms	2008
A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma. Gynecologic oncology, 2008, Volume: 111, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Disease-Free Survival; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2008
Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay. American journal of clinical oncology, 2010, Volume: 33, Issue:4 Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinosarcoma; Cisplatin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Taxoids; Uterine Neoplasms	2010
A rare case of ovarian carcinosarcoma successfully treated with the neoadjuvant chemotherapy of paclitaxel and ifosfamide. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2011, Volume: 31, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinosarcoma; Endometrium; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Ovarian Neoplasms; Paclitaxel	2011
[A case of sarcomatoid carcinoma of the lung successfully treated with carboplatin, paclitaxel and bevacizumab]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2011, Volume: 49, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinosarcoma; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel	2011
Bilateral ovarian teratoma complicated with carcinosarcoma in a 68 year old woman: a case report. BMC cancer, 2011, Jun-03, Volume: 11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Female; Humans; Hysterectomy; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Ovarian Neoplasms; Paclitaxel; Teratoma	2011
CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor). Stem cells (Dayton, Ohio), 2011, Volume: 29, Issue:10 Topics: AC133 Antigen; Animals; Antigens, CD; Antigens, Neoplasm; Carcinosarcoma; Cell Adhesion Molecules; Cell Differentiation; Cell Line, Tumor; Cell Separation; Cell Transformation, Neoplastic; Cisplatin; Drug Resistance, Neoplasm; Epithelial Cell Adhesion Molecule; Estrogen Receptor beta; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glycoproteins; Homeodomain Proteins; Humans; Immunohistochemistry; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Mixed Tumor, Mullerian; Nanog Homeobox Protein; Neoplastic Stem Cells; Octamer Transcription Factor-3; Paclitaxel; PAX2 Transcription Factor; Peptides; SOXB1 Transcription Factors; Uterine Neoplasms; Vimentin; Wnt4 Protein	2011
Optimal debulking surgery followed by paclitaxel/platinum chemotherapy is very effective in treating ovarian carcinosarcomas: a single center experience. Gynecologic and obstetric investigation, 2011, Volume: 72, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Combined Modality Therapy; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies; Survival Analysis	2011
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expression. Gynecologic oncology, 2012, Volume: 125, Issue:1 Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinosarcoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Epothilones; Female; Humans; Inhibitory Concentration 50; Middle Aged; Ovarian Neoplasms; Paclitaxel; Real-Time Polymerase Chain Reaction; Tubulin; Uterine Neoplasms	2012
Beau's lines. QJM : monthly journal of the Association of Physicians, 2013, Volume: 106, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Female; Humans; Ifosfamide; Middle Aged; Nail Diseases; Paclitaxel; Pigmentation Disorders; Renal Dialysis; Uterine Neoplasms	2013
Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: a case report. Taiwanese journal of obstetrics & gynecology, 2012, Volume: 51, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Chemotherapy, Adjuvant; Chordoma; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Paclitaxel; Sacrococcygeal Region; Uterine Neoplasms	2012
Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus. Gynecologic oncology, 2004, Volume: 94, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Clinical Trials as Topic; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2004
Carcinosarcoma of the ovary-a case series. Gynecologic oncology, 2006, Volume: 100, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Paclitaxel; Proportional Hazards Models; Retrospective Studies; Treatment Outcome	2006
Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. International journal of clinical oncology, 2007, Volume: 12, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinosarcoma; Disease-Free Survival; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; North Carolina; Paclitaxel; Pilot Projects; Treatment Outcome; Utah; Uterine Cervical Neoplasms	2007
Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum. Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Survival Rate	2008